2022 Q1 Form 10-Q Financial Statement

#000165495422006125 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $5.288M $4.980M
YoY Change 6.18% 24.0%
Cost Of Revenue $1.232M $1.394M
YoY Change -11.62% 11.25%
Gross Profit $4.056M $3.586M
YoY Change 13.11% 29.79%
Gross Profit Margin 76.7% 72.01%
Selling, General & Admin $2.947M $2.478M
YoY Change 18.93% 17.33%
% of Gross Profit 72.66% 69.1%
Research & Development $275.0K $249.0K
YoY Change 10.44% 28.35%
% of Gross Profit 6.78% 6.94%
Depreciation & Amortization $162.0K $285.0K
YoY Change -43.16% -23.8%
% of Gross Profit 3.99% 7.95%
Operating Expenses $3.368M $2.879M
YoY Change 16.99% 14.47%
Operating Profit $688.0K $707.0K
YoY Change -2.69% 185.08%
Interest Expense $2.000K $1.000K
YoY Change 100.0% -98.28%
% of Operating Profit 0.29% 0.14%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $690.0K $708.0K
YoY Change -2.54% 131.37%
Income Tax $174.0K $163.0K
% Of Pretax Income 25.22% 23.02%
Net Earnings $516.0K $545.0K
YoY Change -5.32% 141.15%
Net Earnings / Revenue 9.76% 10.94%
Basic Earnings Per Share $0.14 $0.15
Diluted Earnings Per Share $0.13 $0.14
COMMON SHARES
Basic Shares Outstanding 3.794K shares 3.769K shares
Diluted Shares Outstanding 3.834K shares 3.817K shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.27M $20.55M
YoY Change 18.12% 26.86%
Cash & Equivalents $24.27M $20.55M
Short-Term Investments
Other Short-Term Assets $879.0K $383.0K
YoY Change 129.5% 58.92%
Inventory
Prepaid Expenses
Receivables $3.950M $2.966M
Other Receivables $0.00 $0.00
Total Short-Term Assets $29.10M $23.90M
YoY Change 21.77% 28.41%
LONG-TERM ASSETS
Property, Plant & Equipment $696.0K $775.0K
YoY Change -10.19% -73.46%
Goodwill $6.376M $6.376M
YoY Change 0.0%
Intangibles $2.339M $2.789M
YoY Change -16.13%
Long-Term Investments
YoY Change
Other Assets $83.00K $93.00K
YoY Change -10.75% -74.24%
Total Long-Term Assets $11.15M $12.18M
YoY Change -8.5% -12.75%
TOTAL ASSETS
Total Short-Term Assets $29.10M $23.90M
Total Long-Term Assets $11.15M $12.18M
Total Assets $40.25M $36.08M
YoY Change 11.55% 10.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $850.0K $589.0K
YoY Change 44.31% 53.79%
Accrued Expenses $1.791M $2.098M
YoY Change -14.63% 97.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.324M $5.428M
YoY Change 16.51% 35.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.580M $1.890M
YoY Change -16.4% -15.09%
Total Long-Term Liabilities $1.580M $1.890M
YoY Change -16.4% -15.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.324M $5.428M
Total Long-Term Liabilities $1.580M $1.890M
Total Liabilities $8.045M $7.580M
YoY Change 6.13% 19.07%
SHAREHOLDERS EQUITY
Retained Earnings $9.750M $6.488M
YoY Change 50.28%
Common Stock $4.000K $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.20M $28.50M
YoY Change
Total Liabilities & Shareholders Equity $40.25M $36.08M
YoY Change 11.55% 10.76%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $516.0K $545.0K
YoY Change -5.32% 141.15%
Depreciation, Depletion And Amortization $162.0K $285.0K
YoY Change -43.16% -23.8%
Cash From Operating Activities $548.0K $1.269M
YoY Change -56.82% 110.8%
INVESTING ACTIVITIES
Capital Expenditures -$21.00K $16.00K
YoY Change -231.25%
Acquisitions $0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$21.00K -$16.00K
YoY Change 31.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $452.0K
YoY Change 122.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -124.0K -$253.0K
YoY Change -50.99% 24.63%
NET CHANGE
Cash From Operating Activities $548.0K $1.269M
Cash From Investing Activities -21.00K -$16.00K
Cash From Financing Activities -124.0K -$253.0K
Net Change In Cash $548.0K $1.000M
YoY Change -45.2% 150.63%
FREE CASH FLOW
Cash From Operating Activities $548.0K $1.269M
Capital Expenditures -$21.00K $16.00K
Free Cash Flow $569.0K $1.253M
YoY Change -54.59% 108.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24271000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23852000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
774000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
675000 USD
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
3950000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3291000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
879000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
750000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
29100000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
27893000 USD
CY2022Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
3317000 USD
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
3301000 USD
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
185000 USD
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
201000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
494000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
456000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
696000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
713000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1469000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1533000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
83000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
94000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
6376000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
6376000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6113000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6005000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2339000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2447000 USD
CY2022Q1 us-gaap Assets
Assets
40248000 USD
CY2021Q4 us-gaap Assets
Assets
39257000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
850000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
695000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1791000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1975000 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
261000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
46000 USD
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3422000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3086000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6324000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5802000 USD
CY2022Q1 isdr Deferred Tax Liability Noncurrent
DeferredTaxLiabilityNoncurrent
141000 USD
CY2021Q4 isdr Deferred Tax Liability Noncurrent
DeferredTaxLiabilityNoncurrent
176000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1580000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1659000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
8045000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
7637000 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3794838 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3793538 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22461000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22401000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9750000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9234000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31620000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40248000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39257000 USD
CY2022Q1 us-gaap Revenues
Revenues
5288000 USD
CY2021Q1 us-gaap Revenues
Revenues
4980000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1232000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1394000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
4056000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
3586000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1683000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1404000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1264000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1074000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
275000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
249000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
146000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
152000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3368000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2879000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
707000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
690000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
163000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
516000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
545000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3794 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3769 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3834 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3817 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
516000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
545000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
7000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
523000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
548000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
28142000 USD
CY2021Q1 isdr Stock Based Compensation Expense
StockBasedCompensationExpense
63000 USD
CY2021Q1 isdr Exercise Of Stock Awards Net Of Tax Amount
ExerciseOfStockAwardsNetOfTaxAmount
199000 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-452000 USD
CY2021Q1 isdr Foreign Currency Translation
ForeignCurrencyTranslation
3000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
545000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
28500000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
31620000 USD
CY2022Q1 isdr Stock Based Compensation Expense
StockBasedCompensationExpense
184000 USD
CY2022Q1 isdr Exercise Of Stock Awards Net Of Tax Amount
ExerciseOfStockAwardsNetOfTaxAmount
58000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-182000 USD
CY2022Q1 isdr Foreign Currency Translation
ForeignCurrencyTranslation
7000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
516000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
32203000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
516000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
545000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
162000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
285000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
101000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-35000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
184000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
63000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
752000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
484000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
55000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
154000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
287000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
398000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
326000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
178000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
548000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1269000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
199000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
452000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-253000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
403000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19556000 USD
CY2022Q1 isdr Effect Of Exchange Rates On Cash
EffectOfExchangeRatesOnCash
16000 USD
CY2021Q1 isdr Effect Of Exchange Rates On Cash
EffectOfExchangeRatesOnCash
-8000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20548000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
3422000 USD
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50250 shares
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
3086000 USD
CY2022Q1 isdr Revenue Recognized Included In The Deferred Revenue
RevenueRecognizedIncludedInTheDeferredRevenue
1391000 USD
CY2021Q1 isdr Revenue Recognized Included In The Deferred Revenue
RevenueRecognizedIncludedInTheDeferredRevenue
1075000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3950000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3291000 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
53000 USD
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">Financial instruments and related items which potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivables. The Company places its cash and temporary cash investments with credit quality institutions. Such cash balances are currently in excess of the FDIC insurance limit of $250,000. To reduce its risk associated with the failure of such financial institutions, each quarter the Company evaluates the rating of the financial institution in which it holds deposits. As of March 31, 2022, the total amount exceeding such limit was $22,307,000. The Company also had cash-on-hand of $113,000 in Europe and $1,640,000 in Canada as of March 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The Company believes it did not have any financial instruments that could have potentially subjected us to significant concentrations of credit risk for any relevant period.</p>
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
22307000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the allowance for doubtful accounts and the valuation of goodwill, intangible assets, deferred tax assets, and stock-based compensation. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
132000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
163000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
174000 USD
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
95000 USD
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
80000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
89750 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M23D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.60
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
41000 shares
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
577000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
624000 USD
CY2019Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1000000 USD
CY2020Q1 isdr Increased In Repurchases Shares
IncreasedInRepurchasesShares
2000000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
179845 shares
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
179845 shares
CY2021Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
11.15
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
179845 shares
CY2021Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
0 USD
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5000000 USD
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
6200 shares
CY2022Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-12-31
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
361000 USD
CY2022Q1 isdr Right Of Use Asset Leases
RightOfUseAssetLeases
1580000 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
89000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
87000 USD
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
18000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
27000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
107000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
114000 USD
CY2022Q1 isdr Weighted Average Non Cancelable Lease Term
WeightedAverageNonCancelableLeaseTerm
P5Y9M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0377 pure
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
269000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
369000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
379000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
389000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
399000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
415000 USD
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2220000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
279000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1941000 USD
CY2022Q1 us-gaap Revenues
Revenues
5288000 USD
CY2022Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2021Q1 us-gaap Revenues
Revenues
4980000 USD
CY2021Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000 pure
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000 USD
CY2022Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0191 pure

Files In Submission

Name View Source Status
0001654954-22-006125-index-headers.html Edgar Link pending
0001654954-22-006125-index.html Edgar Link pending
0001654954-22-006125.txt Edgar Link pending
0001654954-22-006125-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isdr-20220331.xsd Edgar Link pending
isdr-20220331_cal.xml Edgar Link unprocessable
isdr-20220331_def.xml Edgar Link unprocessable
isdr-20220331_lab.xml Edgar Link unprocessable
isdr-20220331_pre.xml Edgar Link unprocessable
isdr_10q.htm Edgar Link pending
isdr_10qimg1.jpg Edgar Link pending
isdr_10qimg2.jpg Edgar Link pending
isdr_10q_htm.xml Edgar Link completed
isdr_ex311.htm Edgar Link pending
isdr_ex312.htm Edgar Link pending
isdr_ex321.htm Edgar Link pending
isdr_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending